EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham Titelbild

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

Jetzt kostenlos hören, ohne Abo

Details anzeigen
ZEITLICH BEGRENZTES ANGEBOT. Nur 0,99 € pro Monat für die ersten 3 Monate. 3 Monate für 0,99 €/Monat, danach 9,95 €/Monat. Bedingungen gelten. Jetzt starten.

Über diesen Titel

 In this episode, we’re joined by Dr. Ness Bermingham, Operating Partner at Khosla Ventures and Chair of the Board at Korro Bio. A scientist-turned-biotech entrepreneur, Ness is passionate about the power of science to tackle some of healthcare’s biggest challenges. Ness co-founded Intellia Therapeutics, a leader in CRISPR gene editing, and Korro Bio, an innovator in RNA editing, driving breakthroughs that translate cutting-edge science into real healthcare solutions. With over 20 years of experience in biotech and healthcare, he’s played a vital role in shaping startups into companies that develop life-changing medicines. Tune in as we dive into Ness’s journey and his insights on innovation in biotech!
Noch keine Rezensionen vorhanden